comparemela.com

Latest Breaking News On - Astrazeneca pharma india limited - Page 4 : comparemela.com

AstraZeneca Pharma India receives permission to import Palivizumab solution for injection

AstraZeneca Pharma India receives permission to import Palivizumab solution for injection
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Palivizumab synagisAstrazeneca pharma indiaZeneca pharma india limitedCentral drugs standard control organisationAstrazeneca pharma india limited

AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg

AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca pharma indiaAstrazeneca pharma india ltdDapagliflozin tabletsZeneca pharma india limitedImport pharmaceutical formulationsNew drugMarketing authorisationDrugs controller generalAstrazeneca pharma india limited

AstraZeneca Pharma India Ltd receives permission for sale and distribution of Trastuzumab deruxtecan

AstraZeneca Pharma India Limited has received a permission in Form CT-20 to Import for sale and distribution of Trastuzumab deruxtecan (Enhertu) 100mg/5mL vial lyophilized powder.

Central drugs standard control organisationAstrazeneca pharma india ltdAstrazeneca pharma indiaHealth servicesZeneca pharma india limitedDirectorate generalAstrazeneca pharma india limited

AstraZeneca Pharma India Ltd Q3 FY2022-23 PAT at Rs 29 30 crores

The Board of Directors of AstraZeneca Pharma India Limited have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23, 9MFY23 at its board meeting.

Astrazeneca pharma indiaAstrazeneca pharma india ltdZeneca pharma india limitedAstrazeneca pharma india limited

AstraZeneca Pharma India receives permission for Dapagliflozin tablets

AstraZeneca Pharma India Ltd has received an Import and Market permission in Form CT-20 from the CDSCO , Directorate General of Health Services, Government of India for Dapagliflozin i.e., Forxiga® tablets of 10 mg - additional indication.

Dapagliflozin forxigaHealth servicesAstrazeneca pharma indiaCentral drugs standard control organisationZeneca pharma india limitedSubsequent new drug approvalDirectorate generalAstrazeneca pharma india limited

vimarsana © 2020. All Rights Reserved.